Compare · DXCM vs MODD
DXCM vs MODD
Side-by-side comparison of DexCom Inc. (DXCM) and Modular Medical Inc. (MODD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and MODD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $31.89B, about 1482.0x MODD ($21.5M).
- Over the past year, DXCM is up 11.2% and MODD is down 87.5% - DXCM leads by 98.7 points.
- DXCM has been more active in the news (12 items in the past 4 weeks vs 7 for MODD).
- DXCM has more recent analyst coverage (25 ratings vs 0 for MODD).
- Company
- DexCom Inc.
- Modular Medical Inc.
- Price
- $84.52+0.74%
- $2.63-7.72%
- Market cap
- $31.89B
- $21.5M
- 1M return
- -5.61%
- +31.50%
- 1Y return
- +11.24%
- -87.48%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- News (4w)
- 12
- 7
- Recent ratings
- 25
- 0
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Modular Medical Inc.
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Latest DXCM
- Director Boehnlein Glenn S was granted 5,841 shares (SEC Form 4)
- New insider Boehnlein Glenn S claimed ownership of 42 shares (SEC Form 3)
- DexCom Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Dexcom Appoints Glenn Boehnlein to Board of Directors
- Dexcom Announces Upcoming Conference Presentation
- EVP Chief People & Culture Off Stern Sadie sold $226,669 worth of shares (2,565 units at $88.37) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 126,043 units (SEC Form 4)
- EVP Chief Legal Compliance Off Brown Michael Jon covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 101,502 units (SEC Form 4) (withholding obligation)
- EVP, Chief Financal Officer Sylvain Jereme M covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.96% to 150,390 units (SEC Form 4) (withholding tax)
- President, CEO, and Director Leach Jacob Steven covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 0.35% to 418,908 units (SEC Form 4) to satisfy withholding tax
- EVP Chief People & Culture Off Stern Sadie covered exercise/tax liability with 1,451 shares, decreasing direct ownership by 1% to 128,608 units (SEC Form 4) (withholding tax)
Latest MODD
- iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
- Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026
- Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
- Modular Medical Inc. filed SEC Form 8-K: Shareholder Director Nominations
- Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
- Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026
- SEC Form EFFECT filed by Modular Medical Inc.
- SEC Form 10-Q filed by Modular Medical Inc.
- SEC Form S-3 filed by Modular Medical Inc.
- Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference